Discover a collection of resources tailored for biopharma companies looking to enter the European market.
Articles
In this article, our experts Samantha Gastine, Anne-Valérie Faucher and Nadia Boehringer examines the evolving pediatric regulatory landscape on both sides of the Atlantic.
Read more
Market intelligence
Our market intelligence report maps national scientific advice across the 27 EU member states: which agency runs a procedure, what it covers, what it costs and how long it takes.…
Read more
Case Studies
How to build MLR and MRC governance for Europe that protects scientific, legal and regulatory consistency while giving affiliates the room to meet local requirements.
Read more
White Papers
A practical guide for biopharma companies preparing for their first EMA interaction. Learn 5 critical steps to reduce delays and align with EU regulatory expectations.
Read more
White Papers
Beyond the regulatory promise: uncover the silent deadlines, timing traps and sequencing logic that determine your real EU orphan exclusivity value.
Read more
Case Studies
Case study on launching a first medicinal product in Europe, covering EU and national requirements, serialization, risk minimization measures, and fast, coordinated market entry.
Read more
Case Studies
Case study on managing the global rollout of a medicinal product after EU approval, from strategy and dossier harmonisation to coordinated Health Authority responses and accelerated worldwide registrations.
Read more
Case Studies
See how AzurBio helps medical device manufacturers achieve ISO 13485 certification and MDR 2017/745 compliance for CE marking and faster EU market access.
Read more
Case Studies
Learn how AzurBio helps manufacturers achieve MDR certification for substance-based medical devices, from documentation gaps to Notified Body expectations.
Read more
Case Studies
Discover how AzurBio secured a French MA for a homeopathic medicinal product with indication, strategy, dossier tips, and key regulatory insights.
Read more
